APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/AllianceAPONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast 05.04.2024 / 10:17 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA enter.
EQS-News: APONTIS PHARMA AG / Key word: Change in Forecast/Alliance
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications.
EQS-News: APONTIS PHARMA AG / Key word: Annual Results/Annual Report
APONTIS PHARMA expects profitable growth again in 2024
28.03.2024 / 07:30 CET/CEST
The issuer is.